Global efforts in the fight against COVID-19
Innovation-led NGS solutions and integrated bioinformaticsGain greater insights into the epidemiology of SARS-CoV-2 with a full spectrum of NGS solutions and integrated bioinformatics pipelines.
Understanding the impact on test resultsStay up today on our continuous surveillance assessing the impact of mutations on assay sensitivity. (Updated January 2021)
Latest – new solutions, webinars and updates
High-throughput SARS-CoV-2 whole genome sequencingExplore how the QIAseq SARS-CoV-2 Primer Panel can help accelerate genomic surveillance of new, highly transmissible SARS-CoV-2 variants.
QIAGEN adds kits for wastewater testing to COVID-19 portfolioQIAGEN adds dPCR platform QIAcuity to growing portfolio of COVID-19 testing solutions for wastewater and mutation testing.
QIAGEN confirms effectiveness of its SARS-CoV-2 PCR testsQIAstat-Dx, NeuMoDx tests, and QIAseq SARS-CoV-2 Primer Panels continue to detect viral mutations extremely effectively.
QIAGEN launches SARS-CoV-2 test for T cell responseQIAGEN to launch QuantiFERON SARS-CoV-2 for research into causes, spread and control of COVID-19 through T cell response
How can we support your lab?
Reach a specialist about SARS-CoV-2 resources.